Petco Reports Q1 2025 Results: Net Sales Dip 2.3%, Operating Income Jumps $33.1M, Adjusted EBITDA Up $13.8M

Reuters
06 Jun
Petco Reports Q1 2025 Results: Net Sales Dip 2.3%, Operating Income Jumps $33.1M, Adjusted EBITDA Up $13.8M

Petco Health and Wellness Company Inc. reported its financial results for the first quarter of 2025, indicating a net sales figure of $1.5 billion, which marks a 2.3% decrease compared to the same period last year. Comparable sales decreased by 1.3% year over year. The company's gross profit margin expanded by approximately 30 basis points, reaching 38.2% as a percentage of net sales. Operating income saw a positive change, improving by $33.1 million to reach $16.4 million. The GAAP net loss improved by $34.8 million, resulting in a net loss of $11.7 million for the quarter. Adjusted EBITDA increased by $13.8 million, totaling $89.4 million. Petco reaffirmed its full year 2025 net sales and earnings outlook and provided guidance for the second quarter of 2025. The company stated that its guidance assumes consistent economic conditions, currency rates, and tax and regulatory landscapes, with tariffs on imports into the U.S. remaining at June 5, 2025 levels. The company emphasized its commitment to executing its strategic plans and achieving sustainable, profitable growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Petco Health and Wellness Company Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA03645) on June 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10